The effect of post-mortem delay on the stability of the protein subunits th
at combine to form NMDA and AMPA type glutamate receptors has been assessed
in samples of human brain tissue. While most of the subunits (i.e. GluR1,
GluR2/3, GluR4, NR1) appear to be stable for up to 18 h post-mortem, the NR
2A and NR2B subunits appear to be proteolyzed rapidly following death. Thes
e results an consistent with the concept that the proteolytic products of N
R2A and NR2B, although at smaller molecular sizes than the full-length prot
ein, are all identifiable on Western blots. Thus, a method is proposed that
allows for the estimation of the levels of these labile proteins even in s
amples obtained up to 18 h post-mortem. Using this method we have estimated
the levels of all AMPA and NMDA receptor subunits; in selected (i.e. hippo
campus. frontal and entorhinal cortex) brain tissue samples obtained from c
ontrol patients and patients who have died with Alzheimer's disease. Modest
decreases in NMDA receptor subunits NR1, NR2A, and NR2B were found in the
hippocampus and in frontal cortex while little or no change in any of these
subunits were documented in entorhinal cortex. Subunits for AMPA receptors
(GluR1, GluR2/3, and GluR4) appeared to show a generalized decrease in all
these tissues. As a surrogate marker for overall decreases due to generali
zed neuronal cell death, levels of neuron-specific enolase were measured in
all tissues and were found to be neatly identical in control and Alzheimer
's brains. (C) 2000 Elsevier Science B.V. All rights reserved.